The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids
Arachidonic acid (AA) has three main metabolic pathways: the cycloxygenases (COXs) pathway, the lipoxygenases (LOXs) pathway, and the cytochrome P450s (CYPs) pathway. AA produces epoxyeicosatrienoic acids (EETs) through the CYPs pathway. EETs are very unstable in vivo and can be degraded in seconds...
Saved in:
Main Authors: | Shan Jiang (Author), Siyi Han (Author), Dao Wen Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
Published: (2020) -
Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019) -
Soluble epoxide hydrolase in the human placenta throughout gestation
by: Tai-Ho Hung, et al.
Published: (2019) -
Association between the soluble epoxide hydrolase gene and preeclampsia
by: Ismail Sari, et al.
Published: (2017) -
The impact of the soluble epoxide hydrolase cascade on periodontal tissues
by: Henrique Ballassini Abdalla, et al.
Published: (2023)